Thesis
A New Era in Diabetic Agents: Hope for Diabetics
Washington State University
Master of Nursing (MN), Washington State University
01/1999
Handle:
https://hdl.handle.net/2376/4029
Abstract
In 1997, there were an estimated 15.7 million diabetics in the United States alone, with an additional 798,000 new cases diagnosed each year. Diabetes mellitus is characterized by abnormal glucose homeostasis, resulting in chronic hyperglycemia. Prolonged hyperglycemia has been associated with retinopathy, peripheral neuropathy, autonomic neuropathy, coronary artery disease, peripheral vascular disease, and nephropathy. As primary care providers, we need to seek out better and more effective treatments for this devastating disease. This paper will discuss: pharmacodynamics, pharmacokinetics, current research, adverse effects, and possible treatment options of diabetic agents lispro, troglitazone, glilnepiride, metformin, and acarbose.
Metrics
5 File views/ downloads
24 Record Views
Details
- Title
- A New Era in Diabetic Agents: Hope for Diabetics
- Creators
- Janice M. Sherer
- Awarding Institution
- Washington State University
- Academic Unit
- Research Projects, College of Nursing
- Theses and Dissertations
- Master of Nursing (MN), Washington State University
- Publisher
- Washington State University; Spokane, Washington
- Identifiers
- 99900590531301842
- Copyright
- http://creativecommons.org/licenses/by-nc-sa/3.0/us; Creative Commons Attribution-NonCommercial-ShareAlike 3.0 United States (CC BY-NC-SA 3.0 US)
- Language
- English
- Resource Type
- Thesis